Tekes, S.Isik, B.Yildiz, T.Simsek, S.Isik, M. R.Budak, T.2024-04-242024-04-2420101310-28181314-3530https://doi.org/10.2478/V10133-010-0019-1https://hdl.handle.net/11468/18963Chronic obstructive pulmonary disease (COPD) is a leading cause of chronic morbidity and mortality. The oxidative stress is increased in COPD patients. Paraoxonase (PON1) in the lung may have a role to protect from oxidative stress. We have investigated a possible relationship between PON1 55 and PON1 192 gene polymorphisms in COPD patients and control subjects. A Total of 62 inpatients of COPD, 45 non-smokers and 35 smokers without COPD were included in the study The serum levels of PON1 were measured. The PON1 genotypes were determined by PCR amplification of the region containing the polymorphism followed by restriction enzyme digestion. The serum levels of PON1 were significantly low in the COPD patients group (p<0.001). There were no statistical differences between the COPD and control groups for PON1 55 polymorphism. The PON1 192 QQ and QR genotypes occurred with similar frequencies in the COPD and control groups with no significant differences while a significant difference was found between the PON1 192 RR allele frequencies (p<0.05) of all groups. PON1 192 gene polymorphism may be considered associated with COPD. PON1 polymorphisms and low PON1 activity levels might be considered as an independent risk factor for COPD.eninfo:eu-repo/semantics/closedAccessCopdPon1Pon1 192 Gene PolymorphismPon1 55 Gene PolymorphismSpirometryArticle24116441647WOS:0002762305000192-s2.0-7795012193210.2478/V10133-010-0019-1Q3Q4